Shares of Mereo BioPharma Group plc (MPH.L) (LON:MPH – Get Free Report) passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 26.50 ($0.35) and traded as low as GBX 26 ($0.35). Mereo BioPharma Group plc (MPH.L) shares last traded at GBX 26.50 ($0.35), with a volume of 49,264 shares traded.
Mereo BioPharma Group plc (MPH.L) Stock Down 1.9 %
The stock has a fifty day moving average price of GBX 26.50 and a two-hundred day moving average price of GBX 26.50. The company has a market cap of £89.76 million and a price-to-earnings ratio of -0.21. The company has a quick ratio of 2.92, a current ratio of 2.98 and a debt-to-equity ratio of 164.26.
Mereo BioPharma Group plc (MPH.L) Company Profile
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor.
See Also
- Five stocks we like better than Mereo BioPharma Group plc (MPH.L)
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- Are Penny Stocks a Good Fit for Your Portfolio?
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- How to Effectively Use the MarketBeat Ratings Screener
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Receive News & Ratings for Mereo BioPharma Group plc (MPH.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mereo BioPharma Group plc (MPH.L) and related companies with MarketBeat.com's FREE daily email newsletter.
